Showing 23,074 news articles about PEP

Filters Content type: Editors' picks Topic: PEP

Post-exposure prophylaxis involves taking a 28-day course of anti-HIV drugs, after possible exposure to HIV. It may be used by healthcare workers (occupational PEP) or after sex (post-exposure prophylaxis after sexual exposure, PEPSE, also known as non-occupational PEP or nPEP).

Ageing & HIV

New Lancet Initiative Seeks to Support Patients Living With HIV as They Age

Editor's pick
TheBodyPro
12 August 2026
Finance & funding

US National Institutes of Health lifts ban on funding research in South Africa

Editor's pick
Science
20 August 2026
PrEP policies & guidelines

South Africa and Zambia’s HIV shot dilemma: Demand versus supply

Editor's pick
Bhekisisa
20 August 2026
The search for a cure

Three-Prong Approach May Clear HIV in Infants

Editor's pick
POZ
20 August 2026
Conference announcements & declarations

Really Rapid Review: International AIDS Conference 2026

Editor's pick
Paul Sax (NEJM Voices)
20 August 2026
Conference announcements & declarations

Anxiety in Paradise: Highlights From the 26th International AIDS Conference in Rio de Janeiro

Editor's pick
TheBody
20 August 2026
TB transmission & prevention

TB preventive treatment for people with HIV shown effective in real-world settings

Editor's pick
EurekAlert!
20 August 2026
Finance & funding

Can Nigeria Take Ownership of Its HIV Funding and Response as Donor Funding Continues to Contract?

Editor's pick
Nigeria Health Watch (Medium)
20 August 2026
Infant feeding

US: Infants Possibly Exposed to HIV via Breast Milk Donated Over Social Media

Editor's pick
MedPage Today
20 August 2026
Access to healthcare

Civil society groups in Argentina and Vietnam challenge patents on paediatric dolutegravir

Editor's pick
ITPC Global
20 August 2026
People with limited treatment options

Hundreds with rare drug-resistant HIV given 'fresh hope' with life-saving new treatment on NHS

Editor's pick
Terrence Higgins Trust
20 August 2026
Conference announcements & declarations

AIDS 2026: Is HIV remission the new cure?

Editor's pick
Positive Living
25 August 2026
Ageing & HIV

Ageing with HIV: global report highlights the need to prepare health systems

Editor's pick
The Conversation
25 August 2026
Ageing & HIV

Canadian team forecasts the healthcare needs of people living with HIV in the coming decade

Editor's pick
CATIE
25 August 2026
Bad science & bogus treatments

Nigerians turn to faith healers as HIV aid dries up

Editor's pick
SciDev.Net
25 August 2026
Ageing & HIV

Opinion: A cure for HIV would be a triumph. But it shouldn’t harm survivors

Editor's pick
STAT (requires free registration)
25 August 2026
Harm reduction

The Opioid Use Treatment Young Americans Can't Access

Editor's pick
Think Global Public Health
25 August 2026
Health services & systems

UNAIDS Framework Pushes for the Protection and Integration of HIV Care

Editor's pick
Inter Press Service
25 August 2026
Epidemiology

Sudan health ministry reports over 13,000 HIV cases, rising disease outbreaks amid war

Editor's pick
Sudan Tribune
25 August 2026
Government, leadership & policy

Canada Has Everything It Needs to End HIV. So Why Are Rates Rising Among Young Gay Men?

Editor's pick
Uncloseted Media
3 August 2026
Employment

North Korea expands mandatory HIV testing to service workers

Editor's pick
Daily NK
7 August 2026
Activism & civil society

Advocates fight back: HIVMA members on the front lines of Florida’s ADAP crisis

Editor's pick
IDSA
5 August 2026
New & experimental HIV treatments

FDA Approves Bixlenvo, a New Daily HIV Combination Pill

Editor's pick
POZ
28 August 2026
HIV treatment for children & young people

Dolutegravir ART Receives FDA Approval for Newborns With HIV

Editor's pick
Medscape (requires free registration)
28 August 2026